These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial. Greco FA; Gray JR; Thompson DS; Burris HA; Erland JB; Barton JH; Litchy S; Houston GA; Butts JA; Webb C; Scott C; Hainsworth JD Cancer; 2002 Sep; 95(6):1279-85. PubMed ID: 12216096 [TBL] [Abstract][Full Text] [Related]
8. Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study. Kubota K; Kawahara M; Ogawara M; Nishiwaki Y; Komuta K; Minato K; Fujita Y; Teramukai S; Fukushima M; Furuse K; Lancet Oncol; 2008 Dec; 9(12):1135-42. PubMed ID: 19013107 [TBL] [Abstract][Full Text] [Related]
9. Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel. Edelman MJ; Clark JI; Chansky K; Albain K; Bhoopalam N; Weiss GR; Giguere JK; Kelly K; Crowley J; Gandara DR Clin Cancer Res; 2004 Aug; 10(15):5022-6. PubMed ID: 15297403 [TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients treated with paclitaxel/carboplatin-based chemotherapy for advanced non-small-cell lung cancer: sequential phase II trials of the Minnie Pearl Cancer Research Network. Hainsworth JD; Gray JR; Morrissey LH; Kalman LA; Hon JK; Greco FA J Clin Oncol; 2002 Jul; 20(13):2937-42. PubMed ID: 12089222 [TBL] [Abstract][Full Text] [Related]
11. [The dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?]. Grossi F; de Marinis F; Frontini L; Gridelli C Tumori; 2008; 94(3):5-14. PubMed ID: 18705422 [No Abstract] [Full Text] [Related]
13. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy. Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673 [TBL] [Abstract][Full Text] [Related]
16. Comparison of cisplatin- and carboplatin-based third-generation chemotherapy in 1,014 Chinese patients with advanced non-small-cell lung cancer. Luo J; Leaw SJ; Xu Y; Zheng D Med Oncol; 2011 Dec; 28(4):1418-24. PubMed ID: 20661668 [TBL] [Abstract][Full Text] [Related]
17. An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group. Pectasides D; Kalofonos HP; Samantas E; Nicolaides C; Papacostas P; Onyenadum A; Visvikis A; Skarlos D; Fountzilas G Anticancer Res; 2001; 21(4B):3005-10. PubMed ID: 11712802 [TBL] [Abstract][Full Text] [Related]
18. A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC). Ginopoulos P; Mastronikolis NS; Giannios J; Karana A; Siabi V; Karvelas F; Rathossis S; Apostolopoulos N; Mastorakou A Lung Cancer; 1999 Jan; 23(1):31-7. PubMed ID: 10100144 [TBL] [Abstract][Full Text] [Related]
19. Lung cancer: therapeutic options for stage IV and recurrent NSCLC. Calvo AR; Belani CP Cancer Treat Res; 2001; 105():189-227. PubMed ID: 11224988 [No Abstract] [Full Text] [Related]
20. Chemotherapy for elderly patients with advanced non-small-cell lung cancer. Bunn PA; Lilenbaum R J Natl Cancer Inst; 2003 Mar; 95(5):341-3. PubMed ID: 12618492 [No Abstract] [Full Text] [Related] [Next] [New Search]